A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer
Clinical trial NCT01113957 · COMPLETED
Trial details
- NCT number
- NCT01113957
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2013-06-01
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.